September 11, 2025 C-Path Concludes 2025 Global Impact Conference with Progress Across Rare Diseases, Neurology and Pediatrics Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception...
September 10, 2025 C-Path’s Global Impact Conference | Every Stage, Every Step: Transforming Lives Through Optimized Drug Development | Day 2 Recap Day 2 of the C-Path Global Impact Conference built on the momentum of opening day...
September 9, 2025 C-Path’s Global Impact Conference | Every Stage, Every Step: Transforming Lives Through Optimized Drug Development | Day 1 Recap Day 1 of Critical Path Institute's Global Impact Conference, #CGIC2025, opened with powerful conversations on accelerating...
September 4, 2025 C-Path’s Translational Therapeutics Accelerator Marks Record Year with Seven BRIDGe Awards Advancing Potential Therapies Across Cancer, Infectious Disease, Neurology and Immunology Program launched in 2022 has grown into a global pipeline partner for academic teams, awarding approximately $2.48 million in 2025
August 21, 2025 HDYO Joins C-Path’s Huntington’s Disease Consortium to Amplify Youth Voices in Drug Development TUCSON, Ariz., August 21, 2025 — Critical Path Institute’s® (C-Path) Huntington’s Disease Regulatory Science Consortium (HD
August 19, 2025 C-Path’s Translational Therapeutics Accelerator Announces $473,000 Grant for Drug Development Project in Primary Sclerosing Cholangitis TUCSON, Ariz, August 19, 2025 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) has awarded a
August 7, 2025 C-Path Awards Translational Therapeutics Accelerator Grant to Advance First-in-Class Antibiotic for Drug-Resistant Lung Infections TUCSON, Ariz., Aug. 7, 2025 ⎯ Critical Path Institute® (C-Path) announced today that its Translational Therapeutics Accelerator
August 7, 2025 Critical Path Institute’s Translational Therapeutics Accelerator Awards $150,000 Grant to Support a Novel Drug Approach in Hereditary Spastic Paraplegia TUCSON, Ariz., August 7, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) has awarded
July 22, 2025 Join Global Leaders in Shaping the Future of Drug Development at C-Path’s 2025 Global Impact Conference Stakeholders across the life sciences ecosystem are invited to attend the 2025 C-Path's Global Impact Conference (CGIC), taking...
July 16, 2025 Critical Path Institute Appoints Dr. Aoife Brennan to Board of Directors C-Path today announced the appointment of Aoife Brennan, M.D., to its Board of Directors. Dr. Brennan brings...